Gene "IGH"
Found 3 records
Gene information
Genetic interaction partners
No data
Modifier statisitcs
Record:
3
Disorder:
1
Vriant:
3
Reference:
1
Effect type:
Pleiotropy(3)
Modifier effect:
Association with lesion counts(2)
,Association with intracerebral hemorrhage(1)
Details:
-
Variant 1:Gene:Genomic location:dbSNP ID:Target disease:Cerebral Cavernous Malformation(DOID_0060669)Effect type:PleiotropyModifier effect:Association with lesion countsEvidence:P=0.003Effect:These results suggest that polymorphisms in inflammatory and immune response pathways contribute to variability in CCM1 disease severity and might be used as predictors of disease severity.Reference:Title:Polymorphisms in inflammatory and immune response genes associated with cerebral cavernous malformation type 1 severity.Species studied:HumanAbstract:Familial cerebral cavernous malformation type 1 (CCM1) is an autosomal dominant disease caused by mutations in the Krev Interaction Trapped 1 (KRIT1/CCM1) gene, and characterized by multiple brain lesions that often result in intracerebral hemorrhage (ICH), seizures, and neurological deficits. Carriers of the same genetic mutation can present with variable symptoms and severity of disease, suggesting the influence of modifier factors. Evidence is emerging that inflammation and immune response play a role in the pathogenesis of CCM. The purpose of this study was to investigate whether common variants in inflammatory and immune response genes influence the severity of familial CCM1 disease, as manifested by ICH and greater brain lesion count.
-
Variant 2:Gene:Genomic location:dbSNP ID:Target disease:Cerebral Cavernous Malformation(DOID_0060669)Effect type:PleiotropyModifier effect:Association with intracerebral hemorrhageEvidence:P=0.01Effect:These results suggest that polymorphisms in inflammatory and immune response pathways contribute to variability in CCM1 disease severity and might be used as predictors of disease severity.Reference:Title:Polymorphisms in inflammatory and immune response genes associated with cerebral cavernous malformation type 1 severity.Species studied:HumanAbstract:Familial cerebral cavernous malformation type 1 (CCM1) is an autosomal dominant disease caused by mutations in the Krev Interaction Trapped 1 (KRIT1/CCM1) gene, and characterized by multiple brain lesions that often result in intracerebral hemorrhage (ICH), seizures, and neurological deficits. Carriers of the same genetic mutation can present with variable symptoms and severity of disease, suggesting the influence of modifier factors. Evidence is emerging that inflammation and immune response play a role in the pathogenesis of CCM. The purpose of this study was to investigate whether common variants in inflammatory and immune response genes influence the severity of familial CCM1 disease, as manifested by ICH and greater brain lesion count.
-
Variant 3:Gene:Genomic location:dbSNP ID:Target disease:Cerebral Cavernous Malformation(DOID_0060669)Effect type:PleiotropyModifier effect:Association with lesion countsEvidence:P=0.006Effect:These results suggest that polymorphisms in inflammatory and immune response pathways contribute to variability in CCM1 disease severity and might be used as predictors of disease severity.Reference:Title:Polymorphisms in inflammatory and immune response genes associated with cerebral cavernous malformation type 1 severity.Species studied:HumanAbstract:Familial cerebral cavernous malformation type 1 (CCM1) is an autosomal dominant disease caused by mutations in the Krev Interaction Trapped 1 (KRIT1/CCM1) gene, and characterized by multiple brain lesions that often result in intracerebral hemorrhage (ICH), seizures, and neurological deficits. Carriers of the same genetic mutation can present with variable symptoms and severity of disease, suggesting the influence of modifier factors. Evidence is emerging that inflammation and immune response play a role in the pathogenesis of CCM. The purpose of this study was to investigate whether common variants in inflammatory and immune response genes influence the severity of familial CCM1 disease, as manifested by ICH and greater brain lesion count.